The acquisition by Globus, which is a provider of implantable devices and instruments used in spinal and orthopedic surgeries, has been in the works since late 2021.
https://www.pharmalive.com/wp-content/uploads/2023/02/GlobusMedical-Nuvasive.jpg450500Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-02-09 07:45:002023-02-09 09:44:00Globus Medical to buy NuVasive in deal valued at about $3 billion
